Synopsys SNPS Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $52.98M-98.6% | $3.9B+171% | $1.44B+1.2% | $1.42B-1.1% | ||
| $72.93M— | —— | —— | —— | ||
| $1.51B+61.1% | $934.47M+9.1% | $856.66M+7.6% | $796.09M+40.0% | ||
| $365.19M+0.9% | $361.85M+11.1% | $325.59M+53.6% | $211.93M-7.5% | ||
| $6.01B-7.1% | $6.47B+88.6% | $3.43B+13.9% | $3.01B+7.3% | ||
| $696.69M+23.7% | $563.01M+2.4% | $549.84M+13.8% | $483.3M+2.3% | ||
| $26.9B+680% | $3.45B+3.1% | $3.35B+7.2% | $3.12B-12.7% | ||
| $12.68B— | —— | —— | —— | ||
| $48.22B+269% | $13.07B+26.5% | $10.33B+9.7% | $9.42B+7.6% | ||
| $164.77M-20.5% | $207.33M+34.1% | $154.61M+311% | $37.58M+37.1% | ||
| $2.25B+61.4% | $1.39B-10.8% | $1.56B-18.4% | $1.91B+25.9% | ||
| $22.12M— | $0— | —— | —— | ||
| $3.72B+40.5% | $2.65B-11.2% | $2.99B+7.6% | $2.77B+15.0% | ||
| $13.46B+86,192% | $15.6M-13.7% | $18.08M-13.2% | $20.82M-17.0% | ||
| $19.9B+391% | $4.05B-2.4% | $4.15B+7.5% | $3.86B+11.7% | ||
| 400M— | —— | —— | —— | ||
| $10.32B+14.8% | $8.98B+33.3% | $6.74B+21.8% | $5.53B+21.6% | ||
| $28.33B+215% | $8.99B+46.3% | $6.15B+11.5% | $5.52B+4.2% | ||
| $48.22B+269% | $13.07B+26.5% | $10.33B+9.7% | $9.42B+7.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Synopsys's total assets?
- Synopsys (SNPS) holds $46.9B in total assets, up 97.4% year over year.
- How much debt does Synopsys have?
- Synopsys carries $10.8B in total debt against $30.5B of shareholders' equity, a debt-to-equity ratio of 0.36.
- How much cash does Synopsys have?
- Synopsys holds $198.1M in cash and equivalents.
- Can Synopsys cover its short-term obligations?
- Its current ratio is 1.43 — current assets exceed current liabilities.
- Where does Synopsys's balance sheet data come from?
- Every line is extracted from Synopsys's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
